Mission: Revolutionize Drug Development & Personalize Care
BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice. Our technology drives the infinite loop between personalized care and research discoveries, leveraging latest science, deep technical expertise, strategic partnerships, and harmonized, diverse data collections. Our high performing genomic data discovery and analytics platform enables flexible data integration, secure analysis and interpretation of molecular and clinical information.
Additionally, BC Platforms has developed a Global Data Partner Network BCRQUEST.com, which provides genomic and clinical cohort data for pharmaceutical and medical research and development.
Founded in 1997 from an MIT Whitehead project spinoff, the Company has a strong scientific heritage underpinned by over 20 years of working in close collaboration with a network of leading researchers, clinicians, developers, manufacturers and vendors. BC Platforms has global operations with its headquarters in Zurich, Switzerland, research and development in Espoo, Finland, and sales and marketing in London, Boston, Vancouver and most recently in Singapore.
BC Platforms got started in 1997 when our founder Timo Kanninen created a database that could store and analyze genetic and phenotypic data together for a MIT Whitehead Institute type 2 diabetes research project. That first database became the foundation for our platform.
Founded in Helsinki, Finland
First own large scale genome data discovery solution is released
Solutions expand to cover biobank market as well as research and pharma
Partnerships expand to offer solutions for biomarker discovery
BC Platforms released the next generation of our solution integrating genomic and clinical data geared for clinical genomics applications
BC Platforms adds partnerships to advance Artificial Intelligence Solutions in healthcare
BC Platforms celebrates 20 years
Launch of complete Personalized Medicine Platform Powered by BC | GENOME. New Partnerships with Microsoft & Google Cloud including Health Care integrators Tieto and Intersystems
Launch of Global, Federated Data Partner Network
BC Platforms Closes $15 million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics
BC Platforms and Kaiser Permanente Win 2020 Microsoft Health Innovation Award for Precision Medicine Collaboration
Meet Our Strategic Partners
Strong partnerships bring the best results
BC Platforms Leverages Latest Science, Unique Technology Capabilities, and Strategic Partnerships to achieve our mission of Revolutionizing Drug Discovery and Personalizing Care.
Our close collaborations with experts across relevant areas help provide a complete framework for our customers to ensure success. We are proud to work closely with a network of leading edge institutions and partners, supporting our strong scientific heritage and driving the best results.
Want to learn more about how we can assist with your real world data?
Don’t hesitate to contact us and one of our experts will reach out to provide you with the answers you need to learn more about your real world data.